{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:39:37Z","timestamp":1766050777687,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","award":["PIF\/SPARC\/07-08\/0006."],"award-info":[{"award-number":["PIF\/SPARC\/07-08\/0006."]}],"id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02996-3","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T21:19:36Z","timestamp":1733433576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Novel Self-Assembled Paclitaxel Nanodispersion Facilitates Rapid In-Vitro\/In-Vivo Dissociation and Protein Binding"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3519-7731","authenticated-orcid":false,"given":"Ajay J.","family":"Khopade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Borole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2996_CR1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/ijms18081733","volume":"18","author":"CPH Yang","year":"2017","unstructured":"Yang CPH, Horwitz SB. Taxol\u00ae: the first microtubule stabilizing agent. Int J Mol Sci. 2017;18:1733. https:\/\/doi.org\/10.3390\/ijms18081733.","journal-title":"Int J Mol Sci"},{"key":"2996_CR2","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA. How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25:2677\u201381. https:\/\/doi.org\/10.1091\/mbc.e14-04-0916.","journal-title":"Mol Biol Cell"},{"key":"2996_CR3","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A, Cremophor EL. The drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37:1590\u20138. https:\/\/doi.org\/10.1016\/S0959-8049(01)00171-X.","journal-title":"Eur J Cancer"},{"issue":"3","key":"2996_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1548-5315(11)70224-8","volume":"6","author":"LD Irizarry","year":"2009","unstructured":"Irizarry LD, Luu TH, McKoy JM, Samaras AT, Fisher MJ, Carias EE, Raisch DW, Calhoun EA, Bennett CL. Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action. Commun Oncol. 2009;6(3):132\u20134.","journal-title":"Commun Oncol"},{"key":"2996_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/onco.13960","volume":"26","author":"R Barroso-Sousa","year":"2021","unstructured":"Barroso-Sousa R, Vaz-Luis I, Di Meglio A, Hu J, Li T, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, Partridge A, Burstein H, Waks AG, Tayob N, Trippa L, Tolaney SM, Hassett MJ, Winer EP, Lin NU. Prospective study testing a simplified paclitaxel premedication regimen in patients with early breast cancer. Oncologist. 2021;26:927\u201333. https:\/\/doi.org\/10.1002\/onco.13960.","journal-title":"Oncologist"},{"issue":"32","key":"2996_CR6","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1200\/JCO.21.01200","volume":"39","author":"OM Lansinger","year":"2021","unstructured":"Lansinger OM, Biedermann S, He Z, Colevas AD. Do steroids Matter? A retrospective review of premedication for taxane chemotherapy and hypersensitivity reactions. J Clin Oncol. 2021;39(32):3583\u201390. https:\/\/doi.org\/10.1200\/JCO.21.01200.","journal-title":"J Clin Oncol"},{"key":"2996_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2023.1157306","volume":"14","author":"M Sousa-Pimenta","year":"2023","unstructured":"Sousa-Pimenta M, Estevinho LM, Szopa A, Basit M, Khan K, Armaghan M, Ibrayeva M, S\u00f6nmez G\u00fcrer E, Calina D, Hano C, Sharifi-Rad J. Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel. Front Pharmacol. 2023;14:1\u201314. https:\/\/doi.org\/10.3389\/fphar.2023.1157306.","journal-title":"Front Pharmacol"},{"key":"2996_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1078155206073589","volume":"12","author":"P Donyai","year":"2006","unstructured":"Donyai P, Sewell GJ. Physical and chemical stability of paclitaxel infusions in different container types. J Oncol Pharm Pract. 2006;12:211\u201322. https:\/\/doi.org\/10.1177\/1078155206073589.","journal-title":"J Oncol Pharm Pract"},{"key":"2996_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0378-5173(95)04128-1","volume":"127","author":"MC Allwood","year":"1996","unstructured":"Allwood MC, Martin H. The extraction of diethylhexylphthalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection. Int J Pharm. 1996;127:65\u201371.","journal-title":"Int J Pharm"},{"key":"2996_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/IJN.S3061","volume":"4","author":"E Miele","year":"2009","unstructured":"Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane\u00ae ABI-007) in the treatment of breast cancer. Int J Nanomed. 2009;4:99\u2013105. https:\/\/doi.org\/10.2147\/IJN.S3061.","journal-title":"Int J Nanomed"},{"key":"2996_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejpb.2023.10.022","volume":"193","author":"A Adick","year":"2023","unstructured":"Adick A, Hoheisel W, Schneid S, Mulac D, Azhdari S, Langer K. Challenges of nanoparticle albumin bound (nab\u2122) technology: comparative study of Abraxane\u00ae with a newly developed albumin-stabilized itraconazole nanosuspension. Eur J Pharm Biopharm. 2023;193:129\u201343. https:\/\/doi.org\/10.1016\/j.ejpb.2023.10.022.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"2996_CR12","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","volume":"17","author":"MR Green","year":"2006","unstructured":"Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, Bhar P, Hawkins MJ. Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 2006;17(8):1263\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdl104.","journal-title":"Ann Oncol"},{"key":"2996_CR13","doi-asserted-by":"publisher","first-page":"19736","DOI":"10.1021\/acsami.1c03065","volume":"13","author":"M Hama","year":"2021","unstructured":"Hama M, Ishima Y, Chuang VTG, Ando H, Shimizu T, Ishida T. Evidence for delivery of Abraxane via a denatured-albumin transport system. ACS Appl Mater Interfaces. 2021;13:19736\u201344. https:\/\/doi.org\/10.1021\/acsami.1c03065.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2996_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/106002809302700119","volume":"27","author":"EA Hartshorn","year":"1993","unstructured":"Hartshorn EA, Gales BJ, Erstad BL. Adverse reactions to human serum albumin. Ann Pharmacother. 1993;27:87\u201394. https:\/\/doi.org\/10.1177\/106002809302700119.","journal-title":"Ann Pharmacother"},{"key":"2996_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/j.1875-9114.1996.tb03024.x","volume":"16","author":"BL Erstad","year":"1996","unstructured":"Erstad BL. Viral infectivity of Albumin and plasma protein fraction. Pharmacotherapy. 1996;16:996\u20131001.","journal-title":"Pharmacotherapy"},{"key":"2996_CR16","unstructured":"Abraxane pack insert 25\/08\/2020\/Suppl-47.\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021660s047lbl.pdf"},{"key":"2996_CR17","doi-asserted-by":"publisher","unstructured":"Foss M, Wilcox BW, Alsop GB, Zhang D. Taxol crystals can masquerade as stabilized microtubules. PLoS ONE. 2008;3(1). https:\/\/doi.org\/10.1371\/journal.pone.0001476.","DOI":"10.1371\/journal.pone.0001476"},{"key":"2996_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/pharmaceutics15061601","volume":"15","author":"B Odeh","year":"2023","unstructured":"Odeh B, El-Sayed B, Knopp MM, Rades T, Blaabjerg LI. Influence of polyvinylpyrrolidone molecular weight and concentration on the precipitation inhibition of supersaturated solutions of poorly soluble drugs. Pharmaceutics. 2023;15:1601. https:\/\/doi.org\/10.3390\/pharmaceutics15061601.","journal-title":"Pharmaceutics"},{"key":"2996_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1248\/cpb.26.118","volume":"26","author":"H Sekikawa","year":"1978","unstructured":"Sekikawa H, Nakano M, Arita T. Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem Pharm Bull. 1978;26:118\u201326.","journal-title":"Chem Pharm Bull"},{"key":"2996_CR20","doi-asserted-by":"publisher","first-page":"77569","DOI":"10.1039\/C6RA19746A","volume":"6","author":"RB Chavan","year":"2016","unstructured":"Chavan RB, Thipparaboina R, Kumar D, Shastri NR. Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth. RSC Adv. 2016;6:77569\u201376.","journal-title":"RSC Adv"},{"key":"2996_CR21","doi-asserted-by":"publisher","unstructured":"Mastropaolo D, Camerman A, Luo Y, Brayer GD, Camerman N. Crystal and molecular structure of paclitaxel (Taxol). Proc Natl Acad Sci. 1995;92:6920\u20136924. https:\/\/doi.org\/10.1073\/pnas.92.15.6920","DOI":"10.1073\/pnas.92.15.6920"},{"issue":"8","key":"2996_CR22","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1016\/j.apsb.2023.02.021","volume":"13","author":"Q Pei","year":"2023","unstructured":"Pei Q, Jiang B, Hao D, Xie Z. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharm Sin B. 2023;13(8):3252\u201376. https:\/\/doi.org\/10.1016\/j.apsb.2023.02.021.","journal-title":"Acta Pharm Sin B"},{"key":"2996_CR23","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.59.321","author":"XJ Xia","year":"2011","unstructured":"Xia XJ, Guo RF, Liu YL, Zhang PX, Zhou CP, Jin DJ, Wang RY. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex. Chem Pharm Bull (Tokyo). 2011. https:\/\/doi.org\/10.1248\/cpb.59.321. 59-321-326.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2996_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jps.21075","volume":"97","author":"K Imamura","year":"2008","unstructured":"Imamura K, Ohyama I, Yokoyama T, Maruyama Y, Imanaka H, Nakanishi K. Temperature scanning FTIR analysis of interactions between sugar and polymer additive in amorphous sugar-polymer mixtures. J Pharm Sci. 2008;97:518\u201328. https:\/\/doi.org\/10.1002\/jps.21075.","journal-title":"J Pharm Sci"},{"key":"2996_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.matbio.2014.03.008","volume":"36","author":"LD Muiznieks","year":"2014","unstructured":"Muiznieks LD, Cirulis JT, Van der Horst A, Reinhardt DP, Wuite GJ, Pom\u00e8s R, Keeley FW. Modulated growth, stability and interactions of liquid-like coacervate assemblies of elastin. Matrix Biol. 2014;36:39\u201350. https:\/\/doi.org\/10.1016\/j.matbio.2014.03.008.","journal-title":"Matrix Biol"},{"issue":"5","key":"2996_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/molecules25051071","volume":"25","author":"F Furlani","year":"2020","unstructured":"Furlani F, Parisse P, Sacco P. On the formation and stability of chitosan\/hyaluronan-based complex coacervates. Molecules. 2020;25(5):1071. https:\/\/doi.org\/10.3390\/molecules25051071.","journal-title":"Molecules"},{"key":"2996_CR27","doi-asserted-by":"publisher","DOI":"10.1021\/la0618317","author":"J Yao","year":"2006","unstructured":"Yao J, Lei S, Huang J, Feng Y, Li Z, Fu H. Vesicle formation and stability in aqueous mixtures of the hydrolyzed copolymer of styrene-maleic anhydride and conventional single-tailed cationic surfactants. Langmuir. 2006. https:\/\/doi.org\/10.1021\/la0618317. 23-526-9531.","journal-title":"Langmuir"},{"key":"2996_CR28","doi-asserted-by":"publisher","first-page":"13475","DOI":"10.1002\/anie.201607117","volume":"55","author":"D Garenne","year":"2016","unstructured":"Garenne D, Beven L, Navailles L, Nallet F, Dufourc EJ, Douliez JP. Sequestration of proteins by fatty acid coacervates for their encapsulation within vesicles. Angew Chem Int Ed Engl. 2016;55:13475\u20139. https:\/\/doi.org\/10.1002\/anie.201607117.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2996_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.31635\/ccschem.021.202000702","volume":"3","author":"L Zhou","year":"2021","unstructured":"Zhou L, Fan Y, Liu Z, Chen L, Spruijt E, Wang Y. A multiresponsive transformation between surfactant-based coacervates and vesicles. CCS Chem. 2021;3:358\u201366. https:\/\/doi.org\/10.31635\/ccschem.021.202000702.","journal-title":"CCS Chem"},{"key":"2996_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/polym16040490","volume":"16","author":"A Fanova","year":"2016","unstructured":"Fanova A, Sotiropoulos K, Radulescu A, Papagiannopoulos A. Advances in small angle neutron scattering on polysaccharide materials. Polymers. 2016;16:490. https:\/\/doi.org\/10.3390\/polym16040490.","journal-title":"Polymers"},{"key":"2996_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0021-9797(02)00020-6","volume":"257","author":"PA Hassan","year":"2003","unstructured":"Hassan PA, Fritz G, Kaler EW. Small angle neutron scattering study of sodium dodecyl sulfate micellar growth driven by addition of a hydrotropic salt. J Colloid Interface Sci. 2003;257:154\u201362. https:\/\/doi.org\/10.1016\/S0021-9797(02)00020-6.","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"2996_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jcis.2012.07.026","volume":"386","author":"H Wang","year":"2012","unstructured":"Wang H, Zhang H, Liu C, Yuan S. Coarse-grained molecular dynamics simulation of self-assembly of polyacrylamide and sodium dodecylsulfate in aqueous solution. J Colloid Interface Sci. 2012;386(1):205\u201311. https:\/\/doi.org\/10.1016\/j.jcis.2012.07.026.","journal-title":"J Colloid Interface Sci"},{"key":"2996_CR33","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1039\/D1CP00211B","volume":"23","author":"C Balbuena","year":"2021","unstructured":"Balbuena C, Gianetti MM, Soul\u00e9 ER. Molecular dynamics simulations of the formation of Ag nanoparticles assisted by PVP. Phys Chem Chem Phys. 2021;23:6677\u201384.","journal-title":"Phys Chem Chem Phys"},{"key":"2996_CR34","doi-asserted-by":"publisher","unstructured":"Wellen BA, Lach EA, Allen HC. Surface pKa of octanoic, nonaoic, and decanoic fatty acids at the air-water interface: applications to atmospheric aerosol chemistry. Phys Chem Chem Phys. 2017:19-26551-26558. https:\/\/doi.org\/10.1039\/C7CP04527A.","DOI":"10.1039\/C7CP04527A"},{"key":"2996_CR35","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1021\/bi101334j","volume":"49","author":"SC Howell","year":"2010","unstructured":"Howell SC, Fraser NJ, Mittal R, Huang L, Travis B, Breyer RM, Sanders CR. Erratum: CHOBIMALT: a cholesterol-based detergent. Biochem. 2010;49:9572\u201383. https:\/\/doi.org\/10.1021\/bi101334j.","journal-title":"Biochem"},{"issue":"1","key":"2996_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-2275(20)38023-8","volume":"24","author":"PF Renshaw","year":"1983","unstructured":"Renshaw PF, Janoff AS, Miller KW. On the nature of dilute aqueous cholesterol suspensions. J Lipid Res. 1983;24(1):47\u201351.","journal-title":"J Lipid Res"},{"key":"2996_CR37","doi-asserted-by":"publisher","unstructured":"Diamant H, Andelman D. Onset of self-assembly in polymer-surfactant systems. Europhys Lett. 1999;48. https:\/\/doi.org\/10.1209\/epl\/i1999-00462-x.","DOI":"10.1209\/epl\/i1999-00462-x"},{"key":"2996_CR38","doi-asserted-by":"publisher","unstructured":"Afzal S, Lone MS, Kaur P, Ahanger FA, Nazir N, Dar AA. Surfactant and Polymer-Based Self-Assemblies for Encapsulation, Protection, and Release of Nutraceuticals. 2022. In: Handbook of Nutraceuticals and Natural Products (eds S. Gopi and P. Balakrishnan). https:\/\/doi.org\/10.1002\/9781119746843.ch16","DOI":"10.1002\/9781119746843.ch16"},{"issue":"5","key":"2996_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5604\/01.3001.0012.7662","volume":"281","author":"M Su\u0142ek","year":"2018","unstructured":"Su\u0142ek M, Jedynak R. The effect of the formation of polymer \/surfactant complexes on selected tribological properties of their aqueous solutions. Q Tribologia. 2018;281(5):117\u201322. https:\/\/doi.org\/10.5604\/01.3001.0012.7662.","journal-title":"Q Tribologia"},{"key":"2996_CR40","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1021\/acs.chemmater.3c02225","volume":"35","author":"J Li","year":"2023","unstructured":"Li J, Fan Y, Gu Q, Zhou X, Sun H, Du J. Homopolymer self-assembly: principles, driving forces, and applications. Chem Mater. 2023;35:10348\u201370. https:\/\/doi.org\/10.1021\/acs.chemmater.3c02225.","journal-title":"Chem Mater"},{"key":"2996_CR41","doi-asserted-by":"crossref","unstructured":"Domenico L, Kiselev M, Magaz\u00f9 S, Calandra P. Amphiphiles self-assembly: Basic concepts and future perspectives of supramolecular approaches. Adv Condens Matter Phys. 2015;2015:1\u201320.","DOI":"10.1155\/2015\/151683"},{"key":"2996_CR42","first-page":"423","volume":"46","author":"MA Kiselev","year":"2001","unstructured":"Kiselev MA, Gryzunov IA, Dobretsov GE, Komarova MN. Size of a human serum albumin molecule in solution. Biofizika. 2001;46:423\u20137.","journal-title":"Biofizika"},{"key":"2996_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijpharm.2014.04.010","volume":"468","author":"C Li","year":"2014","unstructured":"Li C, Li Y, Gao Y, Wei N, Zhao X, Wang C, Li Y, Xiu X, Cui J. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Int J Pharm. 2014;468:15\u201325. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.04.010.","journal-title":"Int J Pharm"},{"key":"2996_CR44","first-page":"5624","volume":"68","author":"N Desai","year":"2008","unstructured":"Desai N, De T, Ci S, Louie L, Trieu V. Characterization and in vitro\/in vivo dissolution of nab-paclitaxel nanoparticles. Cancer Res. 2008;68:5624.","journal-title":"Cancer Res"},{"key":"2996_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00280-021-04235-z","volume":"87","author":"WW Ma","year":"2021","unstructured":"Ma WW, Zhu M, Lam ET, Diamond JR, Dy GK, Fisher GA, Goff LW, Alberts S, Bui LA, Sanghal A, Kothekar M, Khopade A, Chimote G, Faulkner R, Eckhardt SG, Adjei AA, Jimeno A. A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers. Cancer Chemother Pharmacol. 2021;87:779\u201388. https:\/\/doi.org\/10.1007\/s00280-021-04235-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2996_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-016-3736-9","volume":"156","author":"MM Jain","year":"2016","unstructured":"Jain MM, Gupte SU, Patil SG, Pathak AB, Deshmukh CD, Bhatt N, Haritha C, Govind Babu K, Bondarde SA, Digumarti R, Bajpai J, Kumar R, Bakshi AV, Bhattacharya GS, Patil P, Subramanian S, Vaid AK, Desai CJ, Khopade A, Chimote G, Bapsy PP, Bhowmik S. Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II\/III study. Breast Cancer Res Treat. 2016;156:125\u201334. https:\/\/doi.org\/10.1007\/s10549-016-3736-9.","journal-title":"Breast Cancer Res Treat"},{"key":"2996_CR47","doi-asserted-by":"publisher","unstructured":"Zhao M, Lei C, Yang Y, Bu X, Ma H, Gong H, Liu J, Fang X, Hu Z, Fang Q. Abraxane, the nanoparticle formulation of paclitaxel can induce drug resistance by up-regulation of P-gp. PLoS ONE. 2015;10. https:\/\/doi.org\/10.1371\/journal.pone.0131429.","DOI":"10.1371\/journal.pone.0131429"},{"key":"2996_CR48","doi-asserted-by":"publisher","unstructured":"Ji Q, Zhu H, Qin Y, Zhang R, Wang L, Zhang E, Zhou X, Meng R. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1329636Q.","DOI":"10.3389\/fphar.2024.1329636Q"},{"issue":"1","key":"2996_CR49","doi-asserted-by":"publisher","first-page":"L187","DOI":"10.1152\/ajplung.00152.2002","volume":"284","author":"TA John","year":"2003","unstructured":"John TA, Vogel SM, Tiruppathi C, Malik AB, Minshall RD. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol. 2003;284(1):L187\u201396. https:\/\/doi.org\/10.1152\/ajplung.00152.2002.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2996_CR50","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s12325-019-01058-6","volume":"36","author":"O Borg\u00e5","year":"2019","unstructured":"Borg\u00e5 O, Lilienberg E, Bjermo H, Hansson F, Heldring N, Dediu R. Pharmacokinetics of total and unbound paclitaxel after administration of paclitaxel micellar or nab-paclitaxel: an Open, Randomized, Cross-over, explorative study in breast Cancer patients. Adv Ther. 2019;36:2825\u201337. https:\/\/doi.org\/10.1007\/s12325-019-01058-6.","journal-title":"Adv Ther"},{"key":"2996_CR51","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-07-4592","volume":"14","author":"ER Gardner","year":"2008","unstructured":"Gardner ER, Dahut WL, Scripture CD, Jones J, Aragon-Ching JB, Desai N, Hawkins MJ, Sparreboom A, Figg WD. Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel. Clin Cancer Res. 2008;14:4200\u20135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4592.","journal-title":"Clin Cancer Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02996-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:27:44Z","timestamp":1739993264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["2996"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02996-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors were employees of Sun Pharma Advanced Research Company who sponsored the project. The authors declare no other known competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"9"}}